On 14 July Eli Lilly and Company announced the acquisition of Protomer Technologies (“Protomer”), a private biotech company. Protomer’s proprietary peptide- and protein-engineering platform is
Ascensia Diabetes Care has launched a patient assistance programme in the US to provide broader access to its Eversense CGM system. Under the programme eligible
By Ricky Zipp writing for MedTechDive July 2021, “Dexcom wins FDA nod for real-time artificial pancreas systems (APIs), allowing third-party developers access to CGM data
Making sense of the sudden upsurge in sensor use in all thing medical, not just diabetes, we report on the new digital age of electronic
On 14 July Eli Lilly and Company announced the acquisition of Protomer Technologies (“Protomer”), a private biotech company. Protomer’s proprietary peptide- and protein-engineering platform is
A study needs participants to help researchers understand how low blood sugars affect our sleep, moods and our work. Can you take part to help
Researchers at King’s College London are looking for older people with Type 2 diabetes or their carers who have recently started insulin treatment to take
Medtrum announces the imminent launch of their next generation tubeless insulin pump and calibration free Real-Time CGM. Introducing the TouchCare Nano
Children and adolescents with Type 1 diabetes had a higher prevalence of psoriasis than children without the condition, according to an Italian study. The letter
Heaps of news and plenty of KIT updates in this issue. We’ve initiated a new section called ENGAGE as several news items were calling for
